-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

332.O1.6 332. Antithrombotic Therapy: Management of Challenging Patients and Scenarios

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
anticoagulant drugs, Non-Biological, Therapies, Clinically relevant
Sunday, December 2, 2018: 4:30 PM-6:00 PM
Room 33B (San Diego Convention Center)
Moderators:
Kenneth A. Bauer, MD, Beth Israel Deaconess Medical Center and Leslie Skeith, MD, University of Calgary
Disclosures:
Bauer: Janssen: Consultancy. Skeith: CSL Behring: Research Funding; Leo Pharma: Honoraria.
4:30 PM

Robert D. McBane, MD1*, Waldemar E. Wysokinski, MD, PhD1*, Jennifer Le-Rademacher, PhD2*, Aneel A. Ashrani, M.D., M.S.3, Alfonso J Tafur, MD, MS, RPVI, FSVM4*, Krishna Gundabolu, MBBS5, Juliana Perez-Botero, MD6*, Usha Perepu, MD7*, Daniel M. Anderson, MD, MPH8*, Charles Kuzma, MD9, Roberto leon Ferre, MD10*, Stanislav Henkin, MD11*, Charles Lenz, MD12* and Charles Loprinzi, MD13*

1Gonda Vascular Center, Thrombophilia Clinic, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN
2Dept of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic, Rochester, MN
4Cardiology - Vascular Medicine., NorthShore University HealthSystem, Evanston, IL
5University of Nebraska, Lincoln, NE
6Blood Centers of Wisconsin, Milwaukee, WI
7University of Iowa, Iowa City, IA
8Regions Hospital, Metro-Minnesota Community Oncology Research Consortium, Saint Paul, MN
9FirstHealth Outpatient Cancer Center, Pinehurst, NC
10Mayo Clinic, Rochester, MN
11Cardiology, Dartmouth College, Hanover, NH
12Cardiovascular Diseases, Mayo Clinic, Rochester, MN
13Medical Oncology, Mayo Clinic, Rochester, MN

4:45 PM

Jan Beyer-Westendorf, MD1,2, Luise Tittl1*, Christiane Naue, MD1* and Sandra Marten, MD1*

1Thrombosis Research Unit, Department of Medicine I, Division Hematology, University Hospital "Carl Gustav Carus" Dresden, Dresden, Germany
2Kings Thrombosis Service, Department of Hematology, Kings College London, London, United Kingdom

5:00 PM

Margarita Kushnir, MD1, Yun Choi, MD2, Ruth Eisenberg, MS3*, Devika Rao, MD4, Seda Tolu, MD5*, Jackson Gao, MD6*, Wenzhu Mowrey, PhD3* and Henny Heisler Billett, MD7

1Division of Hematology, Department of Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
2NYU Langone Medical Center, New York, NY
3Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY
4Departments of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
5Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
6University of Maryland Medical Center, Baltimore, MD
7Division of Hematology, Departments of Oncology and Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY

5:15 PM

Michael J. Kovacs, MD1, Marc Rodger, MD, MSc2, Philip S. Wells, MD, MSc, FRCP3, Shannon M. Bates, MD, FRCPC, MSc4, Clive Kearon, MB, PhD5, Mark Blostein, MD FRCPC6*, Alejandro Lazo-Langner, MD, MSc7, Susan Kahn, MD8, Sam Schulman, MD, PhD, FRCPC9, Elham Sabri, MSc10*, Susan Solymoss, MD11, Timothy Ramsay, PhD12*, Luljeta Pallaveshi, RN, BA13* and David Anderson, MD14

1London Health Sciences Center -Victoria Hospital, London, ON, Canada
2Ottawa Hospital General Campus, Ottawa, ON, CAN
3Department of Medicine, Ottawa Hospital General Site, Ottawa, ON, Canada
4Division of Hematology, Department of Medicine, McMaster University, Hamilton, ON, Canada
5McMaster University, Juravinski Hospital and Cancer Center, Hamilton, ON, CAN
6Jewish General Hospital, Montreal, QC, CAN
7Department of Medicine, Division of Hematology, London Health Sciences Center, London, ON, Canada
8Center for Clinical Epidemiology and Community Studies, Montreal, QC, CAN
9Department of Medicine, Division of Hematology and Thromboembolism, Department of Obstetrics and Gynecology, The First I.M. Sechenov Moscow State Medical University, Russia, Hamilton, Canada
10Ottawa Health Research Institute (OHRI), Ottawa, QC, Canada
11St. Mary's Hospital Center, McGill University, Montreal, QC, Canada
12Ottawa Hospital Research Institute, Ottawa, ON, Canada
13London Health Sciences Centre, London, ON, Canada
14Dalhousie Unv. and Capital District, Halifax, NS, CAN

5:30 PM

Daniel S Carlson, DO1*, Keith R. McCrae, MD2 and Shruti Chaturvedi, MBBS, MS3

1Cleveland Clinic Foundation, Cleveland, OH
2Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
3Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

5:45 PM

Yan Xu, MD1, Tara Gomes, PhD, MHSc2,3*, Philip S. Wells, MD, MSc, FRCP4, Ana Johnson, PhD5* and Michelle Sholzberg, MD6,7

1Department of Medicine, University of Toronto, Toronto, ON, Canada
2Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada
3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
4Department of Medicine, Ottawa Hospital General Site, Ottawa, ON, Canada
5Queen's University, Kingston, ON, Canada
6Hematology-Oncology Clinical Research Group, Division of Hematology, St. Michael's Hospital and University of Toronto, Toronto, ON, Canada
7St. Michael's Hospital, University of Toronto, Toronto, ON, Canada

*signifies non-member of ASH